🔎 Trials Near Me

መነሻ › አልሰራቲቭ ኮላይቲስ › Virginia

በVirginia ለአልሰራቲቭ ኮላይቲስ የሚደረጉ ክሊኒካዊ ጥናቶች

ለአልሰራቲቭ ኮላይቲስ የሚደረጉ 14 ጥናቶች በVirginia ባሉ ቦታዎች ተሳታፊዎችን እየፈለጉ ነው።

በVirginia ውስጥ ያሉ ከተሞች

Official study text (English)

Extension Study of Long-term Safety and Efficacy of Tulisokibart in Participants With Crohn's Disease or Ulcerative Colitis (MK-7240-011)

  • University of Virginia Health System ( Site 0291), Charlottesville
ተሳታዮችን በመፈለግ ላይደረጃ 3
ለሁሉም እድሜ · ሁሉም ጾታዎች · የተሻሻለው በ2 ኦክቶ 2026 · NCT06651281

Study of Advanced Therapies for the Treatment of Adult Participants With Moderately to Severely Active Crohn's Disease or Ulcerative Colitis

  • Emeritas Research Group /ID# 284388, Lansdowne Town Center
  • GI Alliance - Richmond /ID# 284244, Richmond
ተሳታዮችን በመፈለግ ላይደረጃ 2
እድሜ ከ18 እስከ 75 · ሁሉም ጾታዎች · የተሻሻለው በ2 ኦክቶ 2026 · NCT07697456

A Study of Vedolizumab in Adults With Ulcerative Colitis (UC) or Crohn's Disease (CD) in the Community Setting

  • Gastroenterology Consultants of Southwest Virginia., Roanoke
ተሳታዮችን በመፈለግ ላይደረጃ 4
እድሜ ከ18 እስከ 80 · ሁሉም ጾታዎች · የተሻሻለው በ30 ሴፕቴ 2026 · NCT06581328

Study of XmAb942 in Healthy Participants and Participants With Ulcerative Colitis

  • Xencor Investigative Site, Richmond
ተሳታዮችን በመፈለግ ላይደረጃ 1/2ጤናማ ተሳታዮች ይቀበላሉ
እድሜ ከ18 እስከ 75 · ሁሉም ጾታዎች · የተሻሻለው በ29 ሴፕቴ 2026 · NCT06619990

A Trial to Investigate PALI-2108 Versus Placebo in Participants With Moderately to Severely Active Ulcerative Colitis

  • Site US-013, Richmond
ተሳታዮችን በመፈለግ ላይደረጃ 2
እድሜ ከ18 እስከ 75 · ሁሉም ጾታዎች · የተሻሻለው በ29 ሴፕቴ 2026 · NCT07845487

A Protocol of Icotrokinra Therapy in Adult and Adolescent Participants With Moderately to Severely Active Ulcerative Colitis

  • Gastroenterology Associates of Tidewater, Chesapeake
  • Blue Ridge Medical Research, Lynchburg
ተሳታዮችን በመፈለግ ላይደረጃ 3
እድሜ 12 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ25 ሴፕቴ 2026 · NCT07196748

Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study

  • Gastroenterology Consultants of Southwest Virginia, Roanoke
ተሳታዮችን በመፈለግ ላይደረጃ 3
እድሜ ከ18 እስከ 70 · ሁሉም ጾታዎች · የተሻሻለው በ24 ሴፕቴ 2026 · NCT06937086

Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO

  • VCU Massey Comprehensive Cancer Center, Richmond
ተሳታዮችን በመፈለግ ላይደረጃ 1
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ23 ሴፕቴ 2026 · NCT03816345

LY4268989 (MORF-057) Co-Administered With Mirikizumab in Adults With Moderately to Severely Active Ulcerative Colitis:

  • Clinical Research Partners, LLC, Richmond
  • GI Alliance - Richmond, Richmond
  • Carilion Clinic, Roanoke
ተሳታዮችን በመፈለግ ላይደረጃ 2
እድሜ ከ18 እስከ 80 · ሁሉም ጾታዎች · የተሻሻለው በ22 ሴፕቴ 2026 · NCT07186101

A Master Protocol (AMAZ): A Study of Mirikizumab (LY3074828) in Pediatric Participants With Ulcerative Colitis or Crohn's Disease (SHINE-ON)

  • Pediatric Specialists of Virginia, Fairfax
ተሳታዮችን በመፈለግ ላይደረጃ 3
እድሜ ከ2 እስከ 19 · ሁሉም ጾታዎች · የተሻሻለው በ22 ሴፕቴ 2026 · NCT04844606

LY4268989 in Adults With Moderately to Severely Active Ulcerative Colitis

  • Eximia Research-VA, LLC, Norfolk
ተሳታዮችን በመፈለግ ላይደረጃ 2
እድሜ ከ18 እስከ 80 · ሁሉም ጾታዎች · የተሻሻለው በ22 ሴፕቴ 2026 · NCT07415044

An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Ulcerative Colitis

  • Blue Ridge Medical Research - Site Number: 8400020, Lynchburg
  • Clinical Research Partners - Site Number: 8400080, Richmond
ተሳታዮችን በመፈለግ ላይደረጃ 3
እድሜ ከ16 እስከ 80 · ሁሉም ጾታዎች · የተሻሻለው በ20 ኦገስ 2026 · NCT07184996

A Study of Vedolizumab in Children With Ulcerative Colitis (UC) or Crohn's Disease (CD)

  • Carilion Children's Tanglewood Center, Roanoke
ተሳታዮችን በመፈለግ ላይደረጃ 3
እድሜ 2 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ7 ሜይ 2026 · NCT05442567

Ketogenic and Carnivore (Lion) Diets for Inflammatory Bowel Disease and Rheumatoid Arthritis

  • Resilient Roots: Functional Medicine, Charlottesville
ተሳታዮችን በመፈለግ ላይ
እድሜ ከ18 እስከ 64 · ሁሉም ጾታዎች · የተሻሻለው በ16 ኤፕሪ 2026 · NCT07524244

ከ ClinicalTrials.gov የተገኘ መረጃ፣ በ5 ኦክቶ 2026 የተሰብሰቡ። እያንዳንዱ ጥናት የራሱን ቅድመ ሁኔታ ይወስናል፤ የጥናት ቡድኑ ማን መሳተፍ እንደሚችል ይወስናል።